Difference between revisions of "Team:Newcastle/Results/Endophyte"

Line 1: Line 1:
{{Newcastle/navbar2}}
 
<html>
 
 
<head>
 
<!-- Global site tag (gtag.js) - Google Analytics -->
 
<script async src="https://www.googletagmanager.com/gtag/js?id=UA-123258115-2"></script>
 
<script>
 
  window.dataLayer = window.dataLayer || [];
 
  function gtag(){dataLayer.push(arguments);}
 
  gtag('js', new Date());
 
 
  gtag('config', 'UA-123258115-2');
 
</script>
 
 
  <title>Alternative Roots/Results</title>
 
</head>
 
 
<body id="top">
 
 
    <!-- home
 
    ================================================== -->
 
    <section id="home" class="s-home target-section" data-parallax="scroll" data-image-src="https://static.igem.org/mediawiki/2018/f/f0/T--NEWCASTLE--EndopyteResultsCover.jpg" data-natural-width=3000 data-natural-height=2200 data-position-y=center>
 
 
        <div class="overlay"></div>
 
        <div class="shadow-overlay"></div>
 
 
        <div class="home-content">
 
 
            <div class="row home-content__main">
 
 
                <h3>Alternative Roots</h3>
 
 
                <h1>
 
                    Endophytic Chassis Results
 
                    <br><br>
 
                </h1>
 
<div class="home-content__buttons">
 
                    <a href="#Introduction" class="smoothscroll btn btn--stroke">
 
                        Introduction
 
                    </a>
 
                    <a href="#antibiotic_testing" class="smoothscroll btn btn--stroke">
 
                        Antibiotic Testing
 
                    </a>
 
                          <a href="#Transformation" class="smoothscroll btn btn--stroke">
 
                        Transformation
 
                    </a>
 
  <a href="#new_part" class="smoothscroll btn btn--stroke">
 
                        New Part
 
                    </a>
 
  <a href="#conclusion" class="smoothscroll btn btn--stroke">
 
                        Conclusion
 
                    </a>
 
                </div>
 
 
            </div>
 
 
            <div class="home-content__scroll">
 
                <a href="#notebook" class="scroll-link smoothscroll">
 
                    <span>Scroll Down</span>
 
                </a>
 
            </div>
 
 
            <div class="home-content__line"></div>
 
 
        </div> <!-- end home-content -->
 
 
 
 
        <!-- end home-social -->
 
 
    </section> <!-- end s-home -->
 
 
 
   
 
 
 
    <!-- services
 
    ================================================== -->
 
 
    <section id='Introduction' class="s-services">
 
 
        <div class="row section-header has-bottom-sep" data-aos="fade-up">
 
                <div class="col-full">
 
                            <h3 class="subhead"></h3>
 
                <h1 class="display-2">Introduction</h1>
 
                </div>
 
 
        </div> <!-- end section-header -->
 
 
            <div class="row about-desc" data-aos="fade-up">
 
                <div class="col-full">
 
<p><font size="3">The first steps in developing <i>Pseudomonas</i> sp. (CT 364) involve identifying antibiotics active that it is susceptible to in order to select transformants and optimistaion of transformation protocols. Five antibiotics were tested and two were found to be active against <i>Pseudomonas</i> sp. Working concentrations were identified for each antibiotic using lab automation. Additionally, a new streptomycin resistance cassette was constructed to be used in building plasmids for <i>Pseudomonas</i> sp.</font></p>
 
    </section>
 
<!------------------------------------------------------------------------->
 
 
 
  <section id='antibiotic_testing' class="s-services">
 
 
        <div class="row section-header has-bottom-sep" data-aos="fade-up">
 
                <div class="col-full">
 
                            <h3 class="subhead"></h3>
 
                <h1 class="display-2">Antibiotic Testing
 
            </div>
 
 
        </div> <!-- end section-header -->
 
 
 
            <div class="row about-desc" data-aos="fade-up">
 
                <div class="col-full">
 
 
 
                  <p><font size="3"><i>Pseudomonas</i> sp. (CT 364) was obtained from DSMZ, Germany (DSM No.: 25356). The strain arrived freeze-dried and was revived according to the protocol recommended by DSMZ.(Figure 1)</font></p>
 
 
    <!-- image [Image: First Isolation]
 
    ================================================== -->
 
<img src="https://static.igem.org/mediawiki/2018/6/60/T--Newcastle--First_isolation.jpeg" height="400" width="400">
 
 
                  <p><font size="3"><center>Figure 1. <i>Pseudomonas sp.</i> DSM 25356 plated on tryptone soy agar</center></font></p>
 
 
 
                  <p><font size="3">Screening on tryptone soy agar (TSA) showed <i>Pseudomonas</i> sp. to be resistant to chloramphenicol, kanamycin and carbenicillin. Antibiotic concentrations of 50 and 100 µg/ml were tested with lawns forming on agar containing 100 µg/ml of each antibiotic. (Figures 2, 3 & 4) after 24 hours incubation at 28 °C.</font></p>
 
 
  <!--[Image: 100C]
 
    ================================================== -->
 
<img src="https://static.igem.org/mediawiki/2018/d/d2/T--Newcastle--100_C.jpeg" height="400" width="400">
 
 
 
 
                  <p><font size="3">Figure 2. <i>Pseudomonas sp.</i> DSM 25356 plated on tryptone soy agar containing chloramphenicol (100 µg/ml)</font></p>
 
 
<!-- [Image: Carb 100]
 
    ================================================== -->
 
<img src="https://static.igem.org/mediawiki/2018/b/b3/T--Newcastle--Carb_100.jpeg" height="400" width="400">
 
 
 
<p><font size="3">Figure 3. <i>Pseudomonas sp.</i> DSM 25356 plated on tryptone soy agar containing carbenicillin (100 µg/ml)</font></p>
 
 
<!-- [image: K 100
 
    ================================================== -->
 
<img src="https://static.igem.org/mediawiki/2018/0/03/T--Newcastle--K_100.jpeg" height="400" width="400">
 
 
 
                  <p><font size="3">Figure 4. <i>Pseudomonas sp.</i> DSM 25356 plated on tryptone soy agar containing carbenicillin (100 µg/ml)</p>
 
 
                  <p><font size="3">Screening on TSA showed that <i>Pseudomonas</i> sp. was susceptible to both streptomycin (Figure 5) and gentamicin (Figure 6) with no colony forming units (CFUs) visible on agar containing 50 µg/ml of either antibiotic after 24 hours incubation at 28 °C.</p>
 
 
 
<!-- [Image: 50 S]
 
    ================================================== -->
 
 
<img src="https://static.igem.org/mediawiki/2018/f/f0/T--Newcastle--50_S.jpeg" height="400" width="400">
 
 
 
 
 
              <p><font size="3">Figure 5. <i>Pseudomonas sp.</i> DSM 25356 plated on tryptone soy agar containing streptomycin (100 µg/ml)</p>
 
 
<!-- [Image: 50 G]
 
    ================================================== -->
 
 
<img src="https://static.igem.org/mediawiki/2018/d/df/T--Newcastle--50_G.jpeg" height="400" width="400">
 
 
 
              <p><font size="3">Figure 6. <i>Pseudomonas sp.</i> DSM 25356 plated on tryptone soy agar containing gentamicin (100 µg/ml)</p>
 
 
      <p><font size="3">After identifying which antibiotics were active against <i>Pseudomonas</i> sp. The next step was to identify working concentrations of these antibiotics to be used when selecting transformants. This was done by carrying out minimum inhibitory concentration (MIC) experiments where growth was tested against a range of antibiotic concentrations.</font></p>
 
 
<p><font size="3">The results of our MIC experiments showed a clear dose response between antibiotic concentration and growth of <i>Pseudomonas</i> sp. for both streptomycin and gentamicin (Figures 7 and 8). Gentamicin was found to be the more effective antibiotic with a concentration of 1.5 µg/ml sufficient to prevent growth. A concentration of 6.0 µg/ml of streptomycin was required to prevent growth. A slight increase in absorbance was observed for the positive control for both antibiotics. This is likely due to release of compounds by bacterial cells upon death.</font></p>
 
 
 
      <!-- [Graph: Gentamicin MIC]
 
    ================================================== -->
 
 
 
<img src="https://static.igem.org/mediawiki/2018/6/62/T--Newcastle--Gentamicin_MIC.png" height="800" width="800">
 
 
 
    <p><font size="3">Figure 7. <i>Pseudomonas sp.</i> DSM 25356 grown in tryptone soy broth containing gentamicin at varying concentrations. Cells were grown in 96-well plate format in 200 µl volumes at 37 °C over 24 hours. (n=4 replicates, error bars are standard error of the mean)</font></p>
 
 
 
      <!-- [Graph: Streptomycin MIC
 
    ================================================== -->
 
 
 
<img src="https://static.igem.org/mediawiki/2018/a/ac/T--Newcastle--Streptomycin_MIC.png" height="800" width="800">
 
 
    <p><font size="3">Figure 8. <i>Pseudomonas sp.</i> DSM 25356 grown in tryptone soy broth containing streptomycin at varying concentrations. Cells were grown in 96-well plate format in 200 µl volumes at 37 °C over 24 hours. (n=4 replicates, error bars are standard error of the mean).</font></p>
 
 
<p><font size="3">After identifying the MIC in liquid culture, the MICs in agar were determined for gentamicin as this was the antibiotic being taken forward for transformation.</font></p>
 
 
      <!-- [Image: Genta 4]
 
    ================================================== -->
 
 
<img src="https://static.igem.org/mediawiki/2018/d/d2/T--Newcastle--Genta_4.jpeg" height="400" width="400">
 
 
<p><font size="3"><center>Figure 8. <i>Pseudomonas sp.</i> DSM 25356 plated on tryptone soy agar containing gentamicin (4 µg/ml)<center></font></p>
 
     
 
 
      <!-- [Image: Genta 6]<img src="https://static.igem.org/mediawiki/2018/c/c8/T--Newcastle--Genta_6.jpeg">
 
    ================================================== -->
 
<img src="https://static.igem.org/mediawiki/2018/c/c8/T--Newcastle--Genta_6.jpeg" height="400" width="400">
 
 
<p><font size="3">Figure 9. <i>Pseudomonas sp.</i> DSM 25356 plated on tryptone soy agar containing gentamicin (6 µg/ml)</font></p>
 
 
<p><font size="3">Agar assays showed that concentrations of 2 µg/ml and 4 µg/ml of antibiotic were insufficient to prevent growth of <i>Pseudomonas</i> sp. on agar with a lawn forming on 2 µg/ml and some colonies forming on 4 µg/ml (Figure 7). A gentamicin concentration of 6 µg/ml was sufficient to prevent growth of <i>Pseudomonas</i> sp. as no colonies formed at this concentration (Figure 8).</font></p>
 
 
</section>
 
<section id='Transformation' class="s-services">
 
 
        <div class="row section-header has-bottom-sep" data-aos="fade-up">
 
                <div class="col-full">
 
                            <h3 class="subhead"></h3>
 
                <h1 class="display-2">Transformations
 
                </div>
 
 
        </div> <!-- end section-header -->
 
 
            <div class="row about-desc" data-aos="fade-up">
 
                <div class="col-full">
 
 
<p><font size="3">Once working antibiotic concentrations had been characterised for both antibiotics, transformations could be carried out. Addgene plasmid number 79813 was selected for transformation protocol optimisation due to its <i>Pseudomonas</i> origin of repolication and gentamicin resistance gene. Two minipreps were carried out on the plasmid containing <i>E. coli</i> strain, one of which was aliquoted and spun down giving three DNA solutions of varying DNA concentration (Table1).</font></p>
 
 
<p><font size="3">Table 1. Concentration of DNA solutions obtained from miniprep of E. coli containing Addgene plasmid #79813</font></p>
 
 
<img src="https://static.igem.org/mediawiki/2018/d/d4/T--Newcastle--ChassisResultsTable1.png">
 
 
<br></br>
 
 
<p><font size="3">Four electroporation experiments were carried out, one for each DNA solution and a negative where water was added in place of a DNA solution. Gentamicin resistant colonies formed for each of the DNA solutions with solution 1 giving the highest number of CFUs (Figure 9) and miniprep 3 the lowest (Figure 11). No colonies formed on agar inoculated with the negative control (Figure 12). Colony forming units obtained from each miniprep are displayed in Table 2.</font></p>
 
 
 
 
      <!-- [Image: DSM25256 Transformation 1] <img src="">
 
    ================================================== -->
 
 
 
<img src="https://static.igem.org/mediawiki/2018/5/56/T--Newcastle--Transformation_1.jpeg" height="400" width="400">
 
 
<p><font size="3">Figure 10. <i>Pseudomonas sp.</i> DSM 25356 transformed with gentamicin resistance plasmid from miniprep 1 plated on TSA containing gentamicin (10 μg/ml).</font></p>
 
 
      <!-- [Image: DSM25256 Transformation 2] <img src="">
 
    ================================================== -->
 
 
 
<img src="https://static.igem.org/mediawiki/2018/9/96/T--Newcastle--Transformation_2.jpeg" height="400" width="400">
 
 
 
<p><font size="3">Figure 11. <i>Pseudomonas sp.</i> DSM 25356 transformed with gentamicin resistance plasmid from miniprep 2 plated on TSA containing gentamicin (10 μg/ml).</font></p>
 
 
 
      <!-- [Image: DSM25256 Transformation 3] <img src="">
 
    ================================================== -->
 
 
 
<img src="https://static.igem.org/mediawiki/2018/8/88/T--Newcastle--Transformation_3.jpeg" height="400" width="400">
 
 
<p><font size="3">Figure 12. <i>Pseudomonas sp.</i> DSM 25356 transformed with gentamicin resistance plasmid from miniprep 3 plated on TSA containing gentamicin (10 μg/ml).</font></p>
 
 
 
      <!-- [Image: DSM25356 Transformation Control <img src="">
 
    ================================================== -->
 
 
 
<img src="https://static.igem.org/mediawiki/2018/4/41/T--Newcastle--Transformation_control.jpeg" height="400" width="400">
 
 
<p><font size="3">Figure 13. <i>Pseudomonas sp.</i> DSM 25356 transformed with sterile water (Control) plated on TSA containing gentamicin (10 μg/ml).</font></p>
 
 
<p><font size="3">Table 2. Colonies formed from electrocompetent <i>Pseudomonas</i> sp. inoculated with solutions containing Addgene plasmid #79813</font></p>
 
 
<img src="https://static.igem.org/mediawiki/2018/e/e0/T--Newcastle--ChassisResultsTable2.png">
 
 
<br> </br>
 
 
<p><font size="3">An additional MIC experiment was carried out to characterise gentamicin resistance of the transformant (Figure 20). The transformant was resistant to gentamicin at the highest concentration tested (50 µg/ml).</font></p>
 
 
      <!-- [Graph: Gentamicin Resistance Characterisation] <img src="">
 
    ================================================== -->
 
 
<img src="https://static.igem.org/mediawiki/2018/2/22/T--Newcastle--Gentamicin_Resistance_Characterisation.png" height="800" width="800">
 
 
 
<p><font size="3">Figure 14. <i>Pseudomonas sp.</i> with or without gentamicin resistance plasmid were grown in tryptone soy broth containing gentamicin at varying concentrations. Cells were grown in a 96-well plate format in 200 μl volumes at 28 °C over 24 hours. (n=5 replicates, error bars are standard error of the mean)</font></p>
 
 
  </div>
 
  </div>
 
 
</section>
 
 
<section id='new_part' class="s-services">
 
 
        <div class="row section-header has-bottom-sep" data-aos="fade-up">
 
                <div class="col-full">
 
                            <h3 class="subhead"></h3>
 
                <h1 class="display-2">New Part
 
            </div>
 
 
        </div> <!-- end section-header -->
 
 
 
            <div class="row about-desc" data-aos="fade-up">
 
                <div class="col-full">
 
 
<p><font size="3">A composite part containing the antibiotic resistance gene aadA, an anderson promoter, a strong RBS and a native terminator was designed.  This part conferred resistance to streptomycin, the second antibiotic found to be active against <i>Pseudomonas</i> sp. This part was assembled into pBS1C3 for characterisation and submission to the registry. The Gibson assembly reaction mix is shown in Table 3.</font></p>
 
 
<p><font size="3">Table 3. Volume used of each reagent in Gibson assembly reaction mix.</font></p>
 
 
<img src="https://2018.igem.org/File:T--Newcastle--ChassisResultsTable3.png">
 
 
<br></br>
 
 
<p><font size="3">Following assembly, chemically competent E. coli cells were transformed using each reaction mix. CFUs were obtained for both the streptomycin resistance Gibson assembly reaction mix (Figure 13) and the positive control (Figure 15). No colonies formed on agar inoculated with the negative control (Figure 16).</font></p>
 
 
 
      <!-- [Image: SmR Replicate 1] <img src="">
 
    ================================================== -->
 
 
 
<img src="https://static.igem.org/mediawiki/2018/c/cc/T--Newcastle--SmR_Replicate_1.jpeg" height="400" width="400">
 
 
<p><font size="3">Figure 15. <i>E. coli</i> strain DH5α transformed with streptomycin resistance part BBa_K2797002 plated on LB agar containing streptomycin (50 μg/ml).</font></p>
 
 
 
      <!-- [Image: SmR Positive Control] <img src="">
 
    ================================================== -->
 
 
<img src="https://static.igem.org/mediawiki/2018/6/6a/T--Newcastle--SmR_Positive_Control.jpeg" height="400" width="400">
 
 
<p><font size="3">Figure 16. <i>E. coli</i> strain DH5α transformed with Gibson assembly positive control plated on LB agar containing ampicillin (100 µg/ml)</font></p>
 
 
      <!-- [Image: SmR Negative Control] <img src="">
 
    ================================================== -->
 
 
<img src="https://static.igem.org/mediawiki/2018/6/6b/T--Newcastle--SmR_Negative_Control.jpeg" height="400" width="400">
 
 
 
<p><font size="3">Figure 17. <i>E. coli</i> strain DH5α transformed with sterile water (negative control) plated on LB agar containing streptomycin (50 µg/ml)</font></p>
 
 
<p><font size="3">Following transformation, colonies were re-streaked on agar containing streptomycin (50 µg/ml) (Figure 17) confirming resistance and on agar containing chloramphenicol (25 µg/ml) as resistance was confirmed by the pBS1C3 backbone (Figure 18).</font></p>
 
 
 
      <!-- [Image: SmR Streak] <img src="">
 
    ================================================== -->
 
 
 
<img src="https://static.igem.org/mediawiki/2018/e/e7/T--Newcastle--SmR_Streak.jpeg" height="400" width="400">
 
 
<p><font size="3">Figure 18. <i>E. coli</i> strain DH5α transformed with streptomycin resistance part BBa_K2797002 plated on LB agar containing streptomycin (50 μg/ml)</font></p>
 
 
 
      <!-- [Image: SmR Chloramphenicol] <img src="">
 
    ================================================== -->
 
 
 
<img src="https://static.igem.org/mediawiki/2018/4/4f/T--Newcastle--SmR_Chloramphenicol.jpeg" height="400" width="400">
 
 
<p><font size="3">Figure 19. <i>E. coli</i> strain DH5α carrying the streptomycin resistance part BBa_K2797002 plated on LB agar containing chloramphenicol (25 μg/ml). The part is in the pSB1C3 backbone conferring resistance to chloramphenicol.</font></p>
 
 
<p><font size="3">Streptomycin resistance of the transformed E. coli was compared to the wild type (Figure 19). The transformant was resistant to streptomycin at the highest concentration tested (64 µg/ml).</font></p>
 
 
 
      <!-- [Graph: K2797002 Characterisation] <img src="">
 
    ================================================== -->
 
 
 
 
<img src="https://static.igem.org/mediawiki/2018/1/1d/T--Newcastle--K2797002_Characterisation.png" height="800" width="800">
 
 
<p><font size="3">Figure 20. <i>E. coli</i> DH5α with or without the BBa_K2797002 part in pSB1C3 were grown in LB medium containing streptomycin at varying concentrations. Cells were grown in 96-well plate format in 200 μl volumes at 37 °C over 24 hours. (n=3 replicates, error bars are standard error of the mean).</font></p>
 
 
<section id='conclusion' class="s-services">
 
 
        <div class="row section-header has-bottom-sep" data-aos="fade-up">
 
                <div class="col-full">
 
                            <h3 class="subhead"></h3>
 
                <h1 class="display-2">Conclusions
 
            </div>
 
 
        </div> <!-- end section-header -->
 
 
 
            <div class="row about-desc" data-aos="fade-up">
 
                <div class="col-full">
 
 
<p><font size="3"><i>Pseudomonas</i> sp. was found to be susceptible to two antibiotics, streptomycin and gentamicin. Using a <i>Pseudomonas</i> origin plasmid containing a gentamicin resistance gene electroporation protocols have been optimised for <i>Pseudomonas</i> sp. The new streptomycin resistance part confers strong resistance to streptomycin in <i>E. coli</i>.  </font></p>
 
 
 
 
 
</div>    <!-- end services-list -->
 
 
 
 
</div>       
 
 
    <!-- footer
 
    ================================================== -->
 
 
 
  <section id='references' class="s-services">
 
 
 
        <div class="row section-header has-bottom-sep" data-aos="fade-up">
 
                <div class="col-full">
 
                            <br>
 
<br>
 
<br>
 
<br>
 
<h3 class="subhead"></h3>
 
                <h1 class="display-2">REFERENCES & Attributions</h1>
 
            </div>
 
 
        </div>
 
 
 
 
       
 
 
<button class="collapsible">Click for References & Attributions</button>
 
<div class="content">
 
              <div class="row about-desc" data-aos="fade-up">
 
                <div class="col-full">
 
 
 
 
                  <p><font size="3"></p>
 
 
 
<p class="about-para"><font size="3"><b>Attributions: Frank Eardley and Lewis Tomlinson<b></p>
 
                   
 
 
 
</div>
 
</section>
 
 
 
  
 
   <!-- Java Script
 
   <!-- Java Script

Revision as of 18:03, 15 October 2018

   <script type="text/javascript" src="https://2018.igem.org/Template:Newcastle/JSjquery?
   action=raw&ctype=text/javascript"></script>
   <script type="text/javascript" src="https://2018.igem.org/Template:Newcastle/JSplugins?
   action=raw&ctype=text/javascript"></script>    
   <script type="text/javascript" src="https://2018.igem.org/Template:Newcastle/JSmain?
   action=raw&ctype=text/javascript"></script> 
   <script>

var coll = document.getElementsByClassName("collapsible"); var i;

for (i = 0; i < coll.length; i++) {

 coll[i].addEventListener("click", function() {
   this.classList.toggle("active");
   var content = this.nextElementSibling;
   if (content.style.maxHeight){
     content.style.maxHeight = null;
   } else {
     content.style.maxHeight = content.scrollHeight + "px";
   } 
 });

} </script>

<script> var slideIndex = 1; showSlides(slideIndex);

function plusSlides(n) {

 showSlides(slideIndex += n);

}

function currentSlide(n) {

 showSlides(slideIndex = n);

}

function showSlides(n) {

 var i;
 var slides = document.getElementsByClassName("mySlides");
 var dots = document.getElementsByClassName("dot");
 if (n > slides.length) {slideIndex = 1;}    
 if (n < 1) {slideIndex = slides.length;}
 for (i = 0; i < slides.length; i++) {
     slides[i].style.display = "none";  
 }
 for (i = 0; i < dots.length; i++) {
     dots[i].className = dots[i].className.replace(" active", "");
 }
 slides[slideIndex-1].style.display = "block";  
 dots[slideIndex-1].className += " active";

} </script>

</body>

</html>